How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.

Abstract

Clinicians, researchers, and the public frequently turn to digital channels and social media for up-to-the-minute information on novel therapeutics and vaccines. The value of credible infectious diseases drug information is more apparent in the setting of the coronavirus disease 2019 (COVID-19) pandemic. This viewpoint by the Society of Infectious Diseases Pharmacists (SIDP) provides guidance on utilizing social media platforms to optimize infectious diseases pharmacotherapy. It includes tips for all levels of users but primarily serves a guide for the infectious diseases clinician who has not yet joined social media. It compares various social media platforms and suggests which to begin with based on user needs, recommends efficient curation of social media content, and outlines a stepwise approach (shown below) to increasing engagement over time. This summary will hopefully spur further quality content and engagement regarding drug information from the infectious diseases social media network.

• Authors: Kelli A Cole, Anna Y Zhou, Travis Jones, W Justin Moore, Elisabeth L Chandler, Veronica B Zafonte, Taylor Morrisette, Timothy P Gauthier, Jamie Kisgen, Amanda Barner, Melissa D Johnson, R Dawn Tagare, Julie Ann Justo
• Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 74 Issue Suppl_3 Pg. e23-e33 (05 15 2022) ISSN: 1537-6591 [Electronic] United States
• PMID: 35568481 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].

Topics

• COVID-19
• Communicable Diseases (drug therapy, epidemiology)
• Humans
• Pandemics
• Pharmacists
• Social Media